CorriXR Therapeutics, Inc.
CorriXR Therapeutics, Inc.
About
CorriXR Therapeutics is an oncology-focused biotherapeutics development company with a ground-breaking gene editing platform technology
CorriXR is developing a new paradigm for treatment of solid tumors with a unique CRISPR/Cas biomolecular tool that knocks out the gene for the master transcriptional regulator NRF2
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.